1 Product Name: Bortezomib and intermediates
2 Grade : pharmaceutical grade
3 Usage : bortezomib injcetion
4 Quality :100%nature
5 Product group: Pharmaceutical
6 Purity > 99%
7 Packing:Under your require
8 Color: White crystal powder
9 CAS: 179324-69-7
10 Synonyms: [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid; Velcade; DPBA
11 Molecular Structure
Usage: Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.
Anti-tumour series:
Bortezomib CAS No.:179324-69-7
N-(2-Pyrazinylcarbonyl)-L-phenylalanine CAS No.:114457-94-2
(1R)-(s)-pinanediol 1-ammonium trifluoroacetate-3-methylbutane-1-boronate CAS No.:179324-87-9
(1S,2S,3R,5S)-2,3-Pinanediol CAS No.:18680-27-8
Isobutaneboronic Acid CAS No.:84110-40-7
(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate CAS No.: 247068-85-5
(alphaS)-alpha-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-L-phenylalanine CAS No.: 868540-16-3
Carfilzomib CAS NO.: 868540-17-4
Irinotecan hydrochloride trihydrate CAS NO.:136572-09-3
Irinotecan hydrochloride CAS NO.: 100286-90-6
Irinotecan CAS NO.: 97682-44-5
7-Ethyl-10-hydroxycamptothecin CAS NO.:86639-52-3
1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride CAS NO.: 143254-82-4
關鍵字: bortezomib powder,cas 179324-69-7,multiple myeloma treatment